Eisai
4523.T
#2184
Rank
NZ$14.65 B
Marketcap
NZ$51.93
Share price
0.11%
Change (1 day)
3.67%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.50. an increase over its 2024 EPS that were of NZ$1.69.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8911.85%
2024NZ$1.69-32.63%
2023NZ$2.515.52%
2022NZ$2.38-74.01%
2021NZ$9.15-66.58%
2020NZ$27.3998.24%
2019NZ$13.8217.01%
2018NZ$11.8137.78%
2017NZ$8.57-27.62%
2016NZ$11.8435.33%
2015NZ$8.75-2.82%
2014NZ$9.00-27.66%
2013NZ$12.45-27.49%
2012NZ$17.17-12.67%
2011NZ$19.6688.08%
2010NZ$10.45-11.06%
2009NZ$11.75-390.15%
2008NZ-$4.05-127.78%
2007NZ$14.5811.78%
2006NZ$13.054.38%
2005NZ$12.507.4%
2004NZ$11.6443.03%
2003NZ$8.1425.09%
2002NZ$6.5052.67%
2001NZ$4.2669.76%
2000NZ$2.51